Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CRVS
#2302
Corvus Pharmaceuticals, Inc.
15.1
1
USD
-0.92%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-0.92%
Changement Mensuel
-3.02%
Evolution sur 6 mois
+91.51%
Changement Annuel
+367.80%
Clôture Précédente
15.2
5
Open
15.1
1
Bid
Ask
Low
15.1
1
High
15.1
1
Volume
71
Marchés
Actions des Marchés US
Soins de Santé
CRVS
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
68.14 M
77.11 M
74.51 M
74.68 M
83.99 M
—
Valuation ratios
Enterprise value
355.79 M
240.23 M
283.37 M
547.54 M
642.17 M
1.71 B
Price to earnings ratio
-5.25
-3.09
-3.77
-12.71
-14.53
-34.1
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-12.83
-7.31
-9.57
-16.81
-18.72
-52.41
Price to book ratio
10.02
1.42
1.66
2.39
10.03
15.5
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.18
0.26
-0.09
-0.13
-0.17
-0.13
Return on equity %
-0.37
0.31
-0.1
-0.14
-0.2
-0.13
Return on invested capital %
-63.13
—
—
—
-571.8
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
1.54
4.9
8.91
8.29
6.21
28.31
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.14
-0.11
-0.07
-0.12
-0.12
-0.41
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.85
0.59
0.96
0.79
0.71
3.05
Net current asset value per share
0.89
0.61
0.97
0.81
0.73
3.12
Tangible book value per share
0.53
0.66
1.03
0.87
0.77
3.32
Working capital per share
0.31
0.48
0.87
0.71
0.61
2.67
Book value per share
0.53
0.66
1.03
0.87
0.77
3.32
Nouvelles
Corvus Pharmaceuticals Stock: Strong Clinical Narrative, Already Priced For Success (CRVS)
Cantor Fitzgerald réitère sa note sur l’action Corvus Pharmaceuticals
Cantor Fitzgerald reiterates Corvus Pharmaceuticals stock rating
Oppenheimer relève l’objectif de cours de Corvus Pharmaceuticals à 33$
Oppenheimer raises Corvus Pharmaceuticals stock price target to $33
Corvus Pharmaceuticals, Inc. (CRVS) Q4 2025 Earnings Call Transcript
Corvus Pharmaceuticals en hausse grâce aux données d’essai sur la dermatite atopique
Corvus Pharmaceuticals rises on atopic dermatitis trial data
Corvus Pharmaceuticals publie ses résultats après des données d’essai positives
Corvus Pharmaceuticals earnings on deck after positive trial data
Résultats de Corvus à venir : l’engouement justifie-t-il l’envolée ?
Corvus earnings up next: Can pipeline buzz justify stock surge?